<DOC>
	<DOCNO>NCT00557284</DOCNO>
	<brief_summary>AD disease find child ; focus study mechanism associate child AD induce food allergy . This study randomize , double-blind , placebo-controlled , parallel group trial conduct participant diagnose atopic dermatitis food allergy . The study duration participant approximately 9 week . A total 20 participant recruit entire study . Each arm consist 10 participants.The study enroll 20 child , male female , 1 - 8 year age atopic dermatitis ( AD ) associate food allergen , previously document skin RAST test , enrollment . Atopic dermatitis gastrointestinal ( GI ) symptom score follow throughout study .</brief_summary>
	<brief_title>Efficacy Study Montelukast Atopic Dermatitis Induced Food Allergens</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>1 . Mild moderate atopic dermatitis involve great equal 5 % body surface 2 . Total severity score 2 great 3 4 sign symptom calculate study doctor ( erythema , papulation , lichenification ) 3 . Positive skin ( radioallergosorbent ) RAST test ImmunoCap food environmental allergens 4 . GI symptom total score 2 caregiver GSRS scale revise pediatrics 1 . Participants intolerance allergy montelukast . 2 . History anaphylaxis require hospitalization . 3 . No underlying renal liver disease . 4 . Participants diagnosis severe asthma . 5 . Participants diagnose primary immune deficiency . 6 . Participants use sublingual immunotherapy . 7 . Immunotherapy must maintenance dose minimum 30 day . 8 . If gastrointestinal medication , 30 day stable dose visit 1 maintain throughout study .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Atopic Dermatitis ( Eczema ) associate food allergy</keyword>
</DOC>